---
audienceLevel: patient
cancerTypes:
- myeloproliferative
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- cancer-type
title: Myeloproliferative Neoplasms—Health Professional Version - NCI
url: https://www.cancer.gov/types/myeloproliferative/hp
version: v1
---

# Myeloproliferative Neoplasms—Health Professional Version - NCI

# Myeloproliferative Neoplasms—Health Professional Version

[Go to Patient Version](/types/myeloproliferative)

## Treatment

#### PDQ Treatment Information for Health Professionals

- [Myelodysplastic Syndromes Treatment](/types/myeloproliferative/hp/myelodysplastic-treatment-pdq)
- [Myeloproliferative Neoplasms Treatment](/types/myeloproliferative/hp/myeloproliferative-neoplasms-treatment)
- [Myelodysplastic/Myeloproliferative Neoplasms Treatment](/types/myeloproliferative/hp/mds-mpd-treatment-pdq)

##### More information

- [Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)](/types/leukemia/hp/child-aml-treatment-pdq)
- [Late Effects of Treatment for Childhood Cancer (PDQ®)](/types/childhood-cancers/late-effects-hp-pdq)
- [Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes](/about-cancer/treatment/drugs/myeloproliferative-neoplasms)
- [Clinical Trials to Treat Myelodysplastic Syndromes](https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/myelodysplastic-syndrome/treatment)
- [Clinical Trials to Treat Chronic Myeloproliferative Neoplasms](https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/myeloproliferative-neoplasm/treatment)
- [Clinical Trials to Treat Myelodysplastic/Myeloproliferative Neoplasms](https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/myelodysplastic-myeloproliferative/treatment)

## Causes & Prevention

NCI does not have PDQ evidence-based information about prevention of myeloproliferative neoplasms.

##### More information

- [Cancer Prevention Overview (PDQ®)](/about-cancer/causes-prevention/hp-prevention-overview-pdq)

## Genetics

#### PDQ Genetics Information for Health Professionals

- [DDX41-Associated Myeloid Malignancies](/publications/pdq/information-summaries/genetics/ddx41-hp-pdq)
- [RUNX1-familial Platelet Disorder](/publications/pdq/information-summaries/genetics/runx1-hp-pdq)
- [GATA2 Deficiency Syndrome](/publications/pdq/information-summaries/genetics/gata2)
- [Genetics of Hereditary Hematologic Malignancies](/publications/pdq/information-summaries/genetics/hereditary-hematologic-malignancies)

## Screening

NCI does not have PDQ evidence-based information about screening for myeloproliferative neoplasms.

##### More information

- [Cancer Screening Overview (PDQ®)](/about-cancer/screening/hp-screening-overview-pdq)

## Supportive & Palliative Care

We offer evidence-based supportive and palliative care information
for health professionals on the assessment and management of cancer-related symptoms and conditions.

[Cancer Pain](/about-cancer/treatment/side-effects/pain/pain-hp-pdq)
[Nausea and Vomiting](/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq/)
[Nutrition in Cancer Care](/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq)
[Transition to End-of-Life Care](/about-cancer/advanced-cancer/planning/end-of-life-hp-pdq)
[Last Days of Life](/about-cancer/advanced-cancer/caregivers/planning/last-days-hp-pdq)
[View all Supportive and Palliative Care Summaries](/publications/pdq/information-summaries/supportive-care)
